Jim Wassil, Chief Operating Officer at Vaxcyte, Inc. (PCVX), sold 5,601 shares at $64.29 ($358K) on 2024-01-02, disclosed to the SEC on 2024-01-04.
Scheduled sale ($358k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.71 | 289 | $18K | 5.1% |
| 2 | $63.55 | 1,039 | $66K | 18.4% |
| 3 | $63.55 | 1,039 | $66K | 18.4% |
| 4 | $64.29 | 1,562 | $100K | 28.0% |
| 5 | $64.29 | 1,562 | $100K | 28.0% |
| 6 | $65.15 | 110 |
| $7K |
| 2.0% |
| Total | $63.95 avg | 5,601 | $358K | 100% |
| Filing → |
| PCVX | SELL | 2026-09-02 | $212K | — | Filing → |
| PCVX | SELL | 2026-08-05 | $121K | — | Filing → |
| PCVX | SELL | 2026-07-06 | $127K | — | Filing → |